Clinical significance of miR-22 expression in patients with colorectal cancer

Medical Oncology

Volumn 29, Issue 5, 2012, Pages 3108-3112

  Zhang, Guangjun ^a   Xia, Shusen ^a   Tian, Hongpeng ^a   Liu, Zuoliang ^a   Zhou, Tong ^a  

^a AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

Author keywords

Colorectal cancer; MicroRNAs; miR 22; Prognostic factor

Indexed keywords

MICRORNA 22; MICRORNA; MIRN22 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR INVASION; ADENOCARCINOMA; AGED; BIOSYNTHESIS; CANCER STAGING; COLORECTAL TUMOR; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; AGED; COLORECTAL NEOPLASMS; DOWN-REGULATION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84880266798     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-012-0233-9     Document Type: Article

References (20)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin. 2008;58:71-96.
2. Sun L, Hu H, Peng L, et al. P-cadherin promotes liver metastasis and is associated with poor prognosis in colon cancer. Am J Pathol. 2011;179(1):380-90.
3. Li XM, Wang AM, Zhang J, et al. Down-regulation of miR-126 expression in colorectal cancer and its clinical significance. Med Oncol. 2011;28(4):1054-7.
4. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-97.
5. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5(7):522-31.
6. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 2006;6(4):259-69.
7. Ambros V. The functions of animal microRNAs. Nature. 2004;431:350-5.
8. Slack FJ, Weidhaas JB. MicroRNA in cancer prognosis. N Engl J Med. 2008;359:2720-2.
9. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834-8.
10. Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell. 2009;136:586-91.
11. Kawahigashi Y, Mishima T, Mizuguchi Y, et al. MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs. J Nippon Med Sch. 2009;76:188-97.
12. Xiong J, Yu D, Wei N, et al. An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. FEBS J. 2010;277(7):1684-94.
13. Zhang J, Yang Y, Yang T, et al. microRNA-22 down regulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br J Cancer. 2010;103(8):1215-20.
14. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857-66.
15. Chen CZ. MicroRNAs as oncogenes and tumor suppressors. N Engl J Med. 2005;353:1768-71.
16. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259-69.
17. Poliseno L, Salmena L, Riccardi L, et al. Identification of the mir-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal. 2010;3(117):ra29.
18. Baffa R, Fassan M, Volinia S, et al. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol. 2009;219:214-21.
19. Akihiko T, Oliver S, Syed A, et al. Role of angiogenesis in the development and growth of liver metastasis. Ann Surg Oncol. 2002; 9(7):610-6.
20. Yamakuchi M, Yagi S, Ito T, et al. MicroRNA-22 regulates hypoxia signaling in colon cancer cells. PLoS ONE. 2011; 6(5):e20291.